NCT06648031
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 4, 2024
Completion: Sep 10, 2025